Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
---|
08/22/2002 | US20020115810 Anionic polymerization of functionalized styrene derivatives containing carbazole |
08/22/2002 | US20020115806 Olefin polymerization catalyst system is a reaction product of a metallocenes and a cocatalyst containing fluoroaryl substituted secondary amine or phsophine compound and an anion containing group 13 element which is noncoordinatig |
08/22/2002 | US20020115708 Antiestrogenic and antitumorigenic activities |
08/22/2002 | US20020115707 Process for preparing pure ondansetron hydrochloride dihydrate |
08/22/2002 | US20020115692 Prophylaxis or treatment of a disease or disorder in a mammal in which inappropriate leukocyte trafficking plays a role |
08/22/2002 | US20020115671 Inhibitors of p38-a kinase |
08/22/2002 | US20020115670 1-Aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands |
08/22/2002 | US20020115657 Such as 3-(4-(2-(10,11-dihydro-dibenzo(b,f)azepin-5-yl)-ethoxy)-phenyl)-2 -ethoxypropionic acid; for treatment/ prevention of conditions mediated by peroxisome proliferator-activated receptors (PPAR) |
08/22/2002 | US20020115651 New hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparation |
08/22/2002 | US20020115076 System and apparatus for nucleic acid sequencing of single molecules by polymerase synthesis |
08/22/2002 | DE10108215A1 Pharmazeutische Kombination von Antagonisten von Angiotensin II und Hemmern von Angiotensin II konvertierendem Enzym A pharmaceutical combination of antagonists of angiotensin II inhibitors and angiotensin II converting enzyme |
08/22/2002 | CA2433000A1 Isolation of anthracene and carbazole by melt-crystallization |
08/22/2002 | CA2426535A1 Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors |
08/21/2002 | EP1232144A2 Novel il-8 receptor antagonists |
08/21/2002 | EP1231916A2 Use of indirubine derivatives for making medicines |
08/21/2002 | EP1053224B1 Biphenylsulfonyl cyanamides, method for the production thereof and their utilization as a medicament |
08/21/2002 | EP0675715B1 Cell differentiation induction with mevalonate and mevalonolactone derivatives |
08/21/2002 | CN1365347A Anthracene derivatives and organic electroleuminescents device made by using the same |
08/20/2002 | US6437141 Cyanine dyes and synthesis methods thereof |
08/20/2002 | US6436984 Melatonergic drugs that release nitrogen oxide and melatonin, used for prophylaxis of cardiovascular/nervous system, muscular disorders, antiischemic/inflammatory agents, reperfusion injuries, anemia and alzheimer's disease |
08/20/2002 | US6436965 Inhibition of phosphodiesterase; 3-carbocyclic(alkyl)oxy-2-aryl(alkyl)aminocarbonyl-1-aryl(alkyl)indole or azaindole derivatives |
08/20/2002 | US6436957 Indole derivatives as 5-HT1 agonists |
08/20/2002 | US6436949 Heterocyclically substituted benzamides and their use |
08/20/2002 | US6436939 Treatment of central nervous system disorders including sleep/wake disorders, dementia, alzheimer's disease, epilepsy, narcolepsy, eating disorders, motion sickness, vertigo |
08/20/2002 | US6436923 Compounds and methods for modulation of estrogen receptors |
08/20/2002 | CA2056364C Compositions and methods of effecting contraception |
08/15/2002 | WO2002062773A1 Tricyclic lactam and sultam derivatives and their use as histone deacetylase inhibitors |
08/15/2002 | WO2002062763A2 Inhibition of raf kinase using quinolyl isoquinolyl or pyridyl ureas |
08/15/2002 | WO2002062762A2 Potassium channel openers |
08/15/2002 | WO2002062758A1 Indoline derivative and process for producing the same |
08/15/2002 | WO2002062290A2 Heterocyclic substituted 2-methyl-benzimidazole antiviral agents |
08/15/2002 | WO2002042244A3 Synthesis of chiral intermediates useful in preparing pharmacologically active compounds |
08/15/2002 | WO2002034753A3 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
08/15/2002 | WO2002032419A3 Methods for modulating bladder function |
08/15/2002 | WO2002018369A3 Peptidomimetic protease inhibitors |
08/15/2002 | WO2001072685B1 Polyamine analogues as cytotoxic agents |
08/15/2002 | US20020111461 Peptidomimetic compound for us ein the treatment of diabetes |
08/15/2002 | US20020111385 Synergistic mixtures |
08/15/2002 | US20020111358 Phenoxypropylamine compounds |
08/15/2002 | US20020111351 New hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparation |
08/15/2002 | US20020111344 Antidiabetic agetns, dietetics |
08/15/2002 | US20020111265 Group-15 cationic compounds for olefin polymerization catalysts |
08/15/2002 | CA2437405A1 Potassium channel openers |
08/15/2002 | CA2437134A1 Indoline derivative and process for producing the same |
08/14/2002 | EP1231209A1 Prodrugs of non-steroidal anti-inflammatory and carboxylic acid containing compound |
08/14/2002 | EP1230218A1 Positive modulators of nicotinic receptor agonists |
08/14/2002 | EP1230217A1 Positive modulators of nicotinic receptor agonists |
08/14/2002 | EP1230216A1 Positive modulators of nicotinic receptor agonists |
08/14/2002 | EP1230210A1 Aminoalcohol derivatives useful for the treatment of gastrointestinal disorders |
08/14/2002 | EP1229907A1 Prevention of plaque rupture by acat inhibitors |
08/14/2002 | EP1194375A4 Synthetic porous crystalline mcm-68, its synthesis and use |
08/14/2002 | EP1137739A4 Catalytic cracking process using an mcm-68 catalyst |
08/14/2002 | EP0807111B1 Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same |
08/14/2002 | EP0790974B1 Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitiors |
08/14/2002 | EP0722439B1 Hiv protease inhibitors |
08/14/2002 | DE10103208A1 Gewinnung von Anthracen und Carbazol durch Schmelzkristallisation Of anthracene and carbazole by melt crystallization |
08/14/2002 | CN1364158A Mutilin derivatives and their use as antibacterials |
08/14/2002 | CN1364157A N-(indolcarbonyl) piperazin derivatives |
08/14/2002 | CN1364155A N-Cyanomethyl amides as protease inhibitors |
08/14/2002 | CN1089086C Luminide and macroluminide class of pharmaceuticals |
08/14/2002 | CN1089008C In-vivo diagnostic process by near infrared radiation |
08/13/2002 | US6433175 Pyrroloindoles, pyridoindoles and azepinoindoles as 5-ht2c agonists |
08/13/2002 | US6433009 Treatment of autoimmune, cardiovascular, nervous system, gastrointestinal, respiratory system, and viral disorders; antidiabetic, antiarthritic, antiinflammatory and antidepressant agents |
08/13/2002 | US6433001 1H-indole-3-glyoxylamide sPLA2 inhibitors |
08/13/2002 | US6432987 Substituted N-benzylindol-3-ylglyoxylic acid derivatives having antitumor action |
08/13/2002 | US6432962 Antiinflammatory agents |
08/13/2002 | CA2216633C Synthesis of bis-indolylmaleimides |
08/08/2002 | WO2002060872A1 Synthesis for the preparation of compounds for screening as potential tubulin binding agents |
08/08/2002 | WO2002060867A2 Carbazole derivatives and their uses as heparanase inhibitors |
08/08/2002 | WO2002060859A2 Cyclic derivatives as modulators of chemokine receptor activity |
08/08/2002 | WO2002060438A1 Substituted indoles and their use as integrin antagonists |
08/08/2002 | WO2002060392A2 Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
08/08/2002 | WO2002060340A2 Method for identifying maxi-k channel blockers |
08/08/2002 | WO2002060339A2 Ophthalmic compositions for treating ocular hypertension |
08/08/2002 | WO2002018327A3 Guanidinobenzamides as mc4-r agonists |
08/08/2002 | WO2002006189A3 Aniline derivatives |
08/08/2002 | WO2001094312A3 Indolinone derivatives as protein kinase/phosphatase inhibitors |
08/08/2002 | WO2001056555A3 Use of cox-2 inhibitors for the treatment of constipation |
08/08/2002 | US20020107418 Process to prepare (2S)-2-(dipropylamino)-6-ethoxy-2,3-dihydro-1H-indene-5-carboxamide |
08/08/2002 | US20020107406 Calcium receptor-active compounds |
08/08/2002 | US20020107405 Such as 9-phenyl-3,6-bis(5(carbazol-3-yl)-thiophen-2-yl)-9H-carbazole; electroluminescence; high glass transition temperature |
08/08/2002 | US20020107404 Sulfur-containing indirubin derivatives, their production and use |
08/08/2002 | US20020107266 Amides used particularly in the treatment, prevention or amelioration of one or more symptoms of malaria or Chagas' disease; inhibiting the activity of falcipain or cruzain |
08/08/2002 | US20020107242 Cyclopenta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives |
08/08/2002 | US20020107241 N-heterocyclic derivatives useful for treating or preventing neuronal damage associated with neurological disease |
08/08/2002 | CA2672805A1 Pyrimidine derivatives |
08/08/2002 | CA2436744A1 Method for identifying maxi-k channel blockers for use in lowering elevated intraocular pressure using hek-293 cells |
08/08/2002 | CA2436130A1 Substituted indoles and their use as integrin antagonists |
08/08/2002 | CA2435545A1 Synthesis for the preparation of compounds for screening as potential tubulin binding agents |
08/08/2002 | CA2434485A1 Ophthalmic compositions for treating ocular hypertension |
08/08/2002 | CA2432369A1 Cyclic derivatives as modulators of chemokine receptor activity |
08/07/2002 | EP1229037A1 Heterocyclic N-acetonylbenzamides and their use as fungicides |
08/07/2002 | EP1229028A1 Heterocyclic N-acetonylbenzamides and their use as fungicides |
08/07/2002 | EP1229027A1 Heterocyclic N-acetonylbenzamides and their use as fungicides |
08/07/2002 | EP1228071A1 Pharmaceutically active isoindoline derivatives |
08/07/2002 | EP1228041A2 Indole derivatives and their use as 5ht2a ligands |
08/07/2002 | EP1228037A1 Compounds having mif antagonist activity |
08/07/2002 | EP1228024A1 Novel hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand |
08/07/2002 | EP1227786A1 Agent for dyeing fibres comprising an indoline/indolium derivative |
08/07/2002 | EP1227722A1 Novel succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections |